𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DHPLC screening of cystic fibrosis gene mutations

✍ Scribed by Metka Ravnik-Glavač; Andrew Atkinson; Damjan Glavač; Michael Dean

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
446 KB
Volume
19
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

For the Mutation Detection 2001 Special Issue Denaturing high performance liquid chromatography (DHPLC) using ion-pairing reverse phase chromatography (IPRPC) columns is a technique for the screening of gene mutations. In order to evaluate the potential utility of this assay method in a clinical laboratory setting, we subjected the PCR products of 73 CF patients known to bear CFTR mutations to this analytic technique. We used thermal denaturation profile parameters specified by the MELT program tool, made available by Stanford University. Using this strategy, we determined an initial analytic sensitivity of 90.4% for any of 73 known CFTR mutations. Most of the mutations not detected by DHPLC under these conditions are a-substitutions. This information may eventually help to improve the MELT algorithm. Increasing column denaturation temperatures for one or two degrees above those recommended by the MELT program allowed 100% detection of CFTR mutations tested. By comparing DHPLC methodology used in this study with the recently reported study based on Wavemaker 3.4.4 software (Transgenomic, Omaha, NE) [Le Marechal et al., 2001) and with previous SSCP analysis of CFTR mutations [Ravnik-Glavac 4 et al.

, 1994] we emphasized differences and similarities in order to refine the DHPLC system and discuss the relationship to the alternative approaches. We conclude that the DHPLC method, under optimized conditions, is highly accurate, rapid, and efficient in detecting mutations in the CFTR gene and may find high utility in screening individuals for CFTR mutations. Hum Mutat

📜 SIMILAR VOLUMES

The cystic fibrosis ΔF508 gene mutation
The cystic fibrosis ΔF508 gene mutation and cancer
✍ Rose Ann Padua; Neil Warren; David Grimshaw; Melissa Smith; Christopher Lewis; J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Following the observation that relatives of cystic fibrosis (CF) patients have an increased mortality due to leukaemia, a study was initiated to determine whether leukaemia patients had an increased prevalence of the DF508 CF mutation. No increase in carriers were found among leukaemias; however the

Missense mutations in the cystic fibrosi
Missense mutations in the cystic fibrosis gene in adult patients with asthma
✍ Conxi Lázaro; Rafael de Cid; Jordi Sunyer; Joan Soriano; Javier Giménez; Mónica 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 2 views

Asthma is a complex genetic disorder that affects 5% of adults and 10% of children worldwide. The complete characterization of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified missense mutations in 15% of 144 unrelated adult patients with asthma, but in none of 41 subje

Screening for cystic fibrosis mutations
Screening for cystic fibrosis mutations in Southern France: Identification of a frameshift mutation and two missense variations
✍ Mireille Claustres; Bernard Gerrard; Paule Kjellberg; Marie Desgeorges; Jacques 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB

Communicated by Garry R. Cutting In the search for mutations in the cystic fibrosis gene in patients from the Mediterranean area, we have analysed exons 4,9, 10, 19, and 21 by the single-strand conformation polymorphism (SSCP) technique in 50 patients with at least one non-AF508 chromosome. Ten sam